Biosite’s Triage TOX
This article was originally published in The Gray Sheet
Executive Summary
Drug screen to detect overdose levels of eight commonly abused drugs will complement firm's Triage drugs of abuse panel, Biosite says in a Jan. 17 announcement. The point-of-care assay is performed by placing a urine sample on a protein chip with microcapillary structures that direct the sample's flow through immobilized antibody zones. The protein chip is then inserted into Biosite's Triage MeterPlus to produce a result within 15 minutes. Firm is developing test for stroke to be used with the Triage MeterPlus (1"The Gray Sheet" Aug. 13, 2001, p. 12)...
You may also be interested in...
Biosite Aiming For Stroke Diagnostic PMA Submission In 2003
Biosite's stroke diagnostic markers are more than two times as sensitive as CT scans in detecting ischemic stroke, the firm maintains.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.